该公告为独立文件:
Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Global Healthcare Master Fund, LP(5.96%),Cormorant Global Healthcare GP, LLC(5.96%), etc.
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(5.96%),Cormorant Global Healthcare GP, LLC(5.96%)等
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。